Lipoprotein(a) in the diagnosis of cardiovascular risk. The values of lipoprotein (a) and apolipoprotein B in the adult population of Krasnoyarsk

Lipoprotein(a) in the diagnosis of cardiovascular risk. The values of lipoprotein (a) and apolipoprotein B in the adult population of Krasnoyarsk

Aim. To study the prevalence of elevated concentrations of lipoprotein (a) (Lp(a)) and apolipoprotein B (apoB) associated with high cardiovascular risk in a random sample of the adult Krasnoyarsk population.Material and methods. Lp(a) and apoB concentrations were determined by the immunochemilumines...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. S. Emelyanchik, O. V. Marilovtseva, R. V. Khomchenkov, A. M. Moiseeva, A. A. Chernova, E. Yu. Emelyanchik, S. Yu. Nikulina, A. V. Protopopov
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2023-08-01
Series:	Российский кардиологический журнал
Subjects:	lipoprotein(a) apolipoprotein b cardiovascular risk dyslipidemia screening atherosclerosis coronary artery disease standard lipid panel hyperlipoproteinemia(a) hypercholesterolemia
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/5499
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Phenotype of heterozygous familial hypercholesterolemia caused by deletion of <i>LDLR</i> gene exons 2-10: a case report
by: A. M. Moiseeva, et al.
Published: (2024-12-01)

New opportunities for identifying the risk of cardiovascular events in young people: the role of familial hypercholesterolemia
by: V. S. Emelyanchik, et al.
Published: (2023-01-01)

Lipoprotein (a) Screening, and What's Next?
by: Pasławska Anna, et al.
Published: (2024-12-01)

Aggressive course of atherosclerosis in hyperlipoproteinemia (a): a case series
by: A. M. Namitokov, et al.
Published: (2023-12-01)

Efficacy and safety of tafolecimab a new PCSK9 inhibitor in patients with hyperlipidemia: a systematic review and meta-analysis of randomized controlled trials
by: Ali Ashraf Salah Ahmed, et al.
Published: (2025-06-01)

Impact of hyperlipoproteinemia(a) on the diagnosis of familial hypercholesterolemia and cardiovascular risk assessment
by: A. M. Namitokov, et al.
Published: (2025-04-01)

LIPOPROTEIN(A) MEANING AS AN ADDITIONAL MARKER OF CARDIOVASCULAR RISK IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
by: V. A. Korneva, et al.
Published: (2016-06-01)

Ersonified diagnostic and correction dyslipidemia approach by profiling of apolipoproteins
by: M. A. Kachkovsky, et al.
Published: (2020-12-01)

SPECIFICS OF SUBFRACTIONAL SPECTRUM OF APOLIPOPROTEIN B RELATED LIPOPROTEINES IN CAROTID OR CORONARY ATHEROSCLEROSIS PATIENTS
by: N. E. Gavrilova, et al.
Published: (2016-10-01)

Lipoprotein(a), homocysteine and coronary atherosclerosis in young and middle-aged men
by: M. V. Ezhov, et al.
Published: (2008-10-01)

Lipoprotein(a) and apolipoprotein B as risk factors in coronary heart disease and acute myocardial infarction development
by: G. G. Arabidze
Published: (2005-02-01)

Elevated levels of lipoprotein(a) and low-density lipoprotein cholesterol in familial hypercholesterolemia patients: is dual primary prevention already in sight?
by: Alpo Vuorio, et al.
Published: (2025-07-01)

The era of targeted therapy for hyperlipidemia
by: U. V. Chubykina, et al.
Published: (2024-10-01)

INFLUENCE OF NICOTINIC ACID ON SUBFRACTIONAL SPECTRUM OF LOW, INTERMEDIATE AND HIGH DENSITY LIPOPROTEINS IN PATIENTS WITH HYPERLIPOPROTEINEMIA(а)
by: E. A. Utkina, et al.
Published: (2017-06-01)

Lipoprotein(a) and panvascular disease
by: Ruiyan Xu, et al.
Published: (2025-05-01)

The heterogeneity of lipoproteins and their role in the development of cardiovascular diseases
by: E. A. Utkina, et al.
Published: (2019-06-01)

The role of increased lipoprotein (a) and apolipoprotein B-100 levels, and their link to cholesterol and triglyceride concentration in coronary heart disease patients
by: G. G. Arabidze, et al.
Published: (2006-10-01)

Lipoprotein (a) polymorphism as a risk factor of coronary and carotid atherosclerosis and its complications in women
by: O. I. Afanasyeva, et al.
Published: (2010-12-01)

Lipoprotein(a) as a risk factor for cardiovascular diseases - focus on ischemic stroke (a position paper)
by: Ia. B. Skiba, et al.
Published: (2024-06-01)

Lipoprotein(a) throughout life in women
by: Pablo Corral, et al.
Published: (2024-12-01)

Lipoprotein(a) and Blood Monocytes as Factors for Progression of Carotid Atherosclerosis in Patients with Premature Coronary Heart Disease
by: Alexandra V. Tyurina, et al.
Published: (2025-06-01)

Molecular diagnosis methods in familial hypercholesterolemia
by: Valeriu Moldovan, et al.
Published: (2020-02-01)

Lipoprotein (a) in the Development and Progression of Diabetic Retinopathy: A Systematic Review and Meta-Analysis
by: Stamatios Lampsas, et al.
Published: (2025-06-01)

Lipoprotein(a), atherosclerosis and cardiovascular risk
by: E. A. Polyakova, et al.
Published: (2024-12-01)

APOLIPOPROTEIN A1 GENE AND ITS ROLE IN DYSLIPIDEMIA DEVELOPMENT ACROSS ETHNIC GROUPS OF PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION
by: T. A. Bairova, et al.
Published: (2012-12-01)

Number of blood neutrophil granulocytes is associated with diffuse coronary involvement in patients with increased lipoprotein (a)
by: A. Yu. Filatova, et al.
Published: (2023-11-01)

Clinical role of apolipoproteins A and B
by: G. A. Chumakova, et al.
Published: (2011-12-01)

VARIABILITY IN LEVELS OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA DEPENDING ON AGE AND SEX AND ITS IMPORTANCE IN THE DIAGNOSIS OF THIS DISEASE
by: V. А. Korneva, et al.
Published: (2017-03-01)

Interaction Between Lipoprotein(a) and Other Lipid Molecules: A Review of the Current Literature
by: Hesham Sheashaa, et al.
Published: (2025-01-01)

Organization of lipid centers operation in the Russian Federation — new opportunities
by: M. V. Ezhov, et al.
Published: (2021-07-01)

Role of Lipoprotein(a) in Atherosclerotic Cardiovascular Disease in South Asian Individuals
by: Darshan Patel, et al.
Published: (2025-07-01)

Association of polymorphisms in apolipoprotein A-I gene with plasma lipid profile in population of Saint-Petersburg
by: V. V. Miroshnikova, et al.
Published: (2014-03-01)

Editorial: Cardiovascular risk and lipoprotein(a): beyond LDL cholesterol
by: Giuseppe Mandraffino, et al.
Published: (2025-05-01)

Synergistic effects of lipoprotein (a) and fibrinogen on carotid plaque in patients with coronary artery disease
by: Mengwei Wei, et al.
Published: (2025-02-01)

HDL‐Apolipoprotein in Alzheimer's Disease Revisited: From Periphery to CNS
by: Yihong Huang, et al.
Published: (2025-04-01)

Apolipoprotein A1 deficiency increases macrophage apoptosis and necrotic core development in atherosclerotic plaques in a Bim-dependent manner
by: Alexander S. Qian, et al.
Published: (2025-05-01)

Lipoprotein(a) concentration and the blood content of INFγ-producing T-helpers 17 (Th17/1) in males with premature coronary artery disease
by: A. Yu. Filatova, et al.
Published: (2022-07-01)

LIPOPROTEIN APHERESIS: YESTERDAY, TODAY, TOMORROW. REVIEW
by: U. Julius, et al.
Published: (2018-09-01)

Commentary on: Lipoprotein(a), remote ischemic conditioning, and stroke recurrence in patients with symptomatic intracranial atherosclerotic stenosis
by: Napasiri Putthanbut, et al.
Published: (2025-07-01)

Prevalence and penetrance of pathogenic and likely pathogenic LDLR and APOB gene variants linked to familial hypercholesterolemia and increased risk of ischemic heart disease
by: I. K. Dzhumaniiazova, et al.
Published: (2025-08-01)